1- Go As, Mozaffarian D, Roger VL, et al. Heart disease and Stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129 (3) : e28-292.
2- Reeder B. Scott, MD, PhD, Yiping P. Du, PhD, Joao A. C. Lima, MD and David A. Bluemke, MD, PhD. Advanced cardiac MR imaging of ischemic heart disease. Radiographics 2001; 21: 1047-1074.
3- Kramer M. Christopher, Cardiac MRI, Fundamentals of Diagnostic Radiology, Brant E. William, Helms A. Clyde, 3rd edition, Lippincott Williams & Wilkins, 2007, p. 653-668.
4- Lin C. Eugene, MD, Steven R. Klepac, MD, and Evan J. Samett, MD. Cardiac MRI- Technical Aspects Primer: Overview- eMedicine Radiology, 2008.
5- Finn J. Paul, MD, Kambiz Nael, MD, Vibhas Deshpande, PhD, Osman Ratib, MD, PhD and Gerhard Laub, PhD. Cardiac MR imaging: State of the technology. Radiology 2006; 241: 338-354.
6- Chavhan B. Govind, MD, DNB, Paul S. Babyn, MD, Bhavin G. Jankharia, MD, Hai-Ling M. Cheng, PhD, and Manohar M. Shroff, MD. Steady-State MR Imaging Sequences: Physics, Classification, and Clinical applications. Radiographics 2008; 28: 1147-1160.
7- Sakuma H, Suzawa N, Ichikawa Y et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. American Journal of Roentgenology 2005, 185:95–102.
8- Ruth PL, Monvadi BS, Vivian SL. Non-Ischemic Causes of Delayed Myocardial Hyperenhancement on MRI. American Journal of Roentgenology 2007; 188:1675–1681.
9- Bettencourt N, Chiribiri A, Schuster A, Nagel E. Assessment of Myocardial Ischemia and Viability using Cardiac Magnetic Resonance. Current Heart Failure Reports 2009; 6(3): 142-153.
10- Kitagawa K, Sakuma H, Nagata M, Takeda K. Diagnostic accuracy of stress myocardial perfusion MRI and late gadolinium-enhanced MRI for detecting flow-limiting coronary artery disease: a multicenter study. Eur Radiol 2008, 18: 2808–2816 DOI 10.1007/s00330-008-1097-4
11- Ishida N, Sakuma H, Motoyasu M et al: Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology. 2003; 229:209-216
12- Gebker R, Jahnke C, Paetsch I, et al. Diagnostic Performance of Myocardial Perfusion MR at 3 T in Patients with Coronary Artery Disease. Radiology 2008, 247:57-63.
13- Wagner A, Mahrholdt H, Holly TA et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003, 361:374–379.
14- Kühl HP, Lipke CSA, Krombach GA, et al. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 2006; 27:846 –53.
15- Syed MA, Paterson DI, Ingkanisorn WP, Rhoads KL, Hill J, Cannon RO. Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research. J Cardiovasc Magn reson 2005;7(5):763–768
16- Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 2006; 152:75– 84.